Toxoplasmosis study in non-HIV immune compromised patients
Part of Brain & nervous system, Immune system & allergy, Infections clinical trials.
This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a weakened immune system (for example from an organ transplant, cancer treatment, an autoimmune disease, or certain medications)
- You have had at least one positive toxoplasmosis PCR test (a test that finds the infection's genetic material)
- You do not have HIV
- Your toxoplasmosis was not present at birth (congenital)
- If you have toxoplasmosis only in your eye, you must have a weakened immune system to be included
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have a positive blood test for toxoplasma DNA but no symptoms of toxoplasmosis. It aims to understand the meaning of an isolated positive PCR result.
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
This Phase 2 trial studies whether dexamethasone (a strong anti-inflammatory steroid) helps treat brain toxoplasmosis in adults with HIV. It looks at people who have symptoms and brain scan findings that fit cerebral toxoplasmosis and who have not already taken dexamethasone for more than a few days.
This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.
This study looks for a common parasite (Toxoplasma) in children with epilepsy or ADHD to see if there is a link. It may help families understand more about these conditions.
This study tests a combination of three medications (pyrimethamine, sulfadiazine, and leucovorin) to treat toxoplasmosis—a parasitic infection passed from mother to baby during pregnancy. The goal is to see if early treatment prevents serious complications in infected infants.
Hear when a new Cerebral Toxoplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.